We have observed
14 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PARP inhibitor compounds, compositions and methods of use
FUSED AMINODIHYDROTHIAZINE DERIVATIVES
Intermediates for the preparation of halichondrin B
Fused Aminodihydro-Oxazine Derivatives
PYRIMIDINE FGFR4 INHIBITORS
SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS
MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B
FUSED AMINODIHYDROTHIAZINE DERIVATIVES USEFUL AS BACE INHIBITORS
Intermediates for the synthesis of halichondrin B analogs
METHODS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS
PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE